S303: A PHASE 3 STUDY (ATLAS-PPX) TO EVALUATE EFFICACY AND SAFETY OF FITUSIRAN IN PEOPLE WITH HAEMOPHILIA A OR B WHO HAVE SWITCHED FROM PRIOR CLOTTING FACTOR CONCENTRATE OR BYPASSING AGENT PROPHYLAXIS

• Gili Kenet,
• Beatrice Nolan,
• Bulent Zulfikar,
• Bulent Antmen,
• Peter Kampmann,
• Tadashi Matsushita,
• Chur-Woo You,
• Kateryna Vilchevska,
• Catherine N. Bag,
• Azizan Sharif,
• Flora Peyvandi,
• Guy Young,
• Claude Negrier,
• Christian Sussebach,
• Fadi Shammas,
• Shauna Andersson,
• Baisong Mei,
• Kaan Kavakli

Affiliations

Gili Kenet

1 The National Hemophilia Centre, The Amalia Biron Thrombosis Research Institute, Sheba Medical Centre, Tel Hashomer, Tel Aviv University,, Tel Aviv, Israel

Beatrice Nolan

2 Children’s Health Ireland at Crumlin, Dublin, Ireland

Bulent Zulfikar

3 Division of Pediatric Hematology-Oncology, Istanbul University Oncology Institute,, Istanbul, Turkey

Bulent Antmen

4 Department of Pediatric Hematology/Oncology and Bone Marrow Transplantation Unit, Faculty of Medicine, Acibadem University, Adana Hospital, Adana, Turkey

Peter Kampmann

5 Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

Tadashi Matsushita

6 Department of Transfusion Medicine, Nagoya University Hospital, Nagoya, Japan

Chur-Woo You

7 Department of Pediatrics, Daejeon Eulji Medical Center, Eulji University School of Medicine, Daejeon, Korea, Rep. of South

Kateryna Vilchevska

8 National Children’s Specialized Hospital OHMATDYT, Kyiv, Ukraine

Catherine N. Bag

9 Department of Haematology, Glasgow Royal Infirmary, Glasgow, United Kingdom

Azizan Sharif

10 Hospital Sultanah Aminah, Johor Bahru, Malaysia

Flora Peyvandi

11 Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy

Guy Young

13 Hemostasis and Thrombosis Center, Cancer and Blood Diseases Institute, Children’s Hospital Los Angeles, University of Southern California Keck School of Medicine, LA, CA, United States

Claude Negrier

14 Louis Pradel University Hospital, Claude Bernard University Lyon 1, Lyon, France

Christian Sussebach

15 Sanofi, Frankfurt, Hessen, Germany

Fadi Shammas

16 Sanofi, Montreal, Quebec, Canada

Shauna Andersson

17 Sanofi, Cambridge, MA, United States

Baisong Mei

17 Sanofi, Cambridge, MA, United States

Kaan Kavakli

18 Kaan Department of Haematology, Ege University Faculty of Medicine, Children’s Hospital, Izmir, Turkey